COVID-19 Vaccination: Covishield Vaccine-Oxford Astrazeneca Vaccine-Efficacy of Vaccine-Novavax Vaccine and its efficacy

 Need of the Hour is the early Vaccination Drive to Ease further Loss of Life and Livelihood

Three COVID-19 Vaccines have been Approved for the Vaccination drive in Major Democratic Countries- First is the Pfizer-Moderna vaccine in US, second is the Oxford-AstraZeneca in UK and third is Covishield in India. Researchers and Scientists across the World is watching the situation very closely to see any adverse effects of the Vaccines. Let's have a look on the Procedure to Administer the Vaccine and also about its Efficacy.

COVISHIELD VACCINE:

A Subject Expert Committee(SEC) of Drug Controller General of India(DCGI) has given the Approval to the Covishield Vaccine Candidate developed by Pune Based Serum Institute of India(SII). Govt has claimed that Covishield Vaccine is likely to be Practically available for use within second week in Jan, 2021. Experts and Researchers has said that the Vaccine is very much Equivalent to Oxford-AstraZeneca Vaccine. SII is testing the Efficacy of the Vaccine by conducting Trial in 1600 Volunteers in India. It is found that Interim Data based on Trial in the UK and Brazil suggest that the Vaccine protected 70% of the Volunteers from showing Disease Symptoms.

Covishield Vaccine is very much similar to the Oxford-AstraZeneca Vaccine and also is very significant for India since SII has tied up with AstraZeneca to deploy the Vaccine in the Country. Experts also Claim that there is no Evidence that Current Vaccine will fail to Protect against COVID-19 Variants reported from the UK or South Africa. For more Info about mutation of virus Please visit to Link.(https://pandemic365.blogspot.com/2020/12/mutation-in-corona-virus-reasons-of.html).

On the other hand, DCGI Committee has sought Additional Data on Covaxin, Bharat Biotech has Developed the Vaccine and has been asked to furnish more Data about the Efficacy of the Covaxin Vaccine Candidate.

Govt has clearly explained that the cost of Vaccine will be Maximum upto Rs 1000 for two necessary doses for the public depending on the final trial and results. For Registration of Vaccination Related Info Please Visit the Link(https://pandemic365.blogspot.com/2020/12/coronavirus-or-covid-19-vaccination.html).

To enhance the look

Oxford-AstraZeneca Vaccine:

The Govt of UK has aprroved the Oxford University and AstraZeneca Vaccine Candidate for Emergency Supply in the Country. The Vaccine will be used to Vaccinate People in early Jan, 2021. Actually Vaccine is developed by the Oxford University Vaccine Group and marketed by AstraZeneca. Some Salients points in favour of Vaccine are as follows-

-Unlike Pfizer-Moderna Vaccine that requires minus 70 to minus 80 degree celsius cold storage the Oxford Vaccine can be stored at 2 to 8 Degree celsius of Temperature.

-According to the Experts the Vaccine protected against COVID-19 in 62% of those given two full doses and 90% of those given one and half doses.

European Medicine Agency has emphasized on Additional Scientific information on the issues related to Quality, Safety, and Efficacy of the Vaccine to be Deployed for Emergency use.

Few Published results related to Vaccine Efficacy-

-There is only 62% efficacy when two full doses are administered within four weeks apart.

-In UK it is found that efficacy increasing to 73%, 22 days after the first dose when the second dose is delayed. Following the research regulator has permitted the second dose to be administer 4-12 weeks after the first jab.

Novavax Vaccine:

Novavax is an American vaccine development company, it has developed a vaccine against COVID-19. Vaccine Efficacy is nearly  90% when used in UK and it showed efficacy of nearly 60% when injected in South Africa. Taking cognizance of these efficacy, Serum Institute of India, based on Pune, India, has decided to mass produce the Novavax Vaccine in India.

Serum Institute of India:

SII is now the World's largest Vaccine manufacturer by number of Doses produced and sold Globally which includes Polio Vaccine as well as Diptheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, and Rubella Vaccine. It is estimated that about 65% of the Children in the World receive at least one Vaccine manufactured by SII. Vaccine manufactured by SII are accredited by the WHO and are being used in around 170 Countries across the Globe in their National Immunization Programs, saving millions of lives throughout the World.(https://www.seruminstitute.com/about_us.php)

Bharat Biotech:

Vision- To offer affordable, safe, and effective healthcare solutions to combat mankind's dreaded illness and to thus eradicate or at least control their occurance in the years to come.

Mission- We seek to address the healthcare needs of the 5.8 billion people in the emerging markets by driving innovation and being a front runner in research and development of new Vaccines and Bio-therapeutics.(https://www.bharatbiotech.com/)